Article Details
Retrieved on: 2023-01-14 00:22:39
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The chief catalyst for the program was regulatory change, said Nicola Broughton, the senior scientist responsible for device technology at CPI.
Article found on: medtech.pharmaintelligence.informa.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here